{"DataElement":{"publicId":"8177838","version":"1","preferredName":"Cytogenetics Bone Marrow Minimal Residual Disease Outcome Percentage 2 Decimal Place Value","preferredDefinition":"The 2 decimal place percentage value for the cytogenetics bone marrow minimal residual disease outcome.","longName":"CYTO_BM_MRD_RSLT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8177827","version":"1","preferredName":"Cytogenetic Analysis Bone Marrow Measurable Residual Disease Outcome","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes._Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques._The result of an action.","longName":"8177824v1.0:8177825v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2626353","version":"1","preferredName":"Cytogenetic Analysis","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","longName":"C18280","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DFFACB0-002E-03CB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-13","modifiedBy":"ONEDATA","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11131823","version":"1","preferredName":"Bone Marrow Measurable Residual Disease Outcome","preferredDefinition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes._Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques._The result of an action.","longName":"C12431:C3896:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow","conceptCode":"C12431","definition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E66FAD9A-2085-081A-E053-731AD00ADDF0","latestVersionIndicator":"Yes","beginDate":"2022-08-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-17","modifiedBy":"KUMMEROA","dateModified":"2022-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA79DD6-9DDF-207D-E053-4EBD850A9269","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-27","modifiedBy":"CLOHNES","dateModified":"2022-09-07","changeDescription":null,"administrativeNotes":"9/7/22 Released DEC per AK for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7278997","version":"1","preferredName":"Laboratory Procedure Outcome Percentage 2 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action._A fraction or ratio with 100 understood as the denominator._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"7278997v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7278996","version":"1","preferredName":"Laboratory Procedure Outcome Percentage Integer::2 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The result of an action.:A fraction or ratio with 100 understood as the denominator.:A number with no fractional part, including the negative and positive numbers as well as zero.::2:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"7278996v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4D94DBD-218B-23A9-E053-F662850A01A5","latestVersionIndicator":"Yes","beginDate":"2020-05-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-05-04","modifiedBy":"ONEDATA","dateModified":"2020-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4D94DBD-219C-23A9-E053-F662850A01A5","latestVersionIndicator":"Yes","beginDate":"2020-05-04","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-05-04","modifiedBy":"MALUMK","dateModified":"2020-07-30","changeDescription":". Released. 07/30/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the value for the cytogenetics bone marrow minimal residual disease outcome?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Bone marrow cytogenetics MRD results:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA82F90-DE85-3F2F-E053-4EBD850A3A51","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-27","modifiedBy":"CLOHNES","dateModified":"2022-09-07","changeDescription":null,"administrativeNotes":"9/7/22 Released CDE per AK for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}